SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000904454-02-000092
Filing Date
2002-05-30
Accepted
2002-05-30 14:00:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 ONYX SCHEDULE 13D s13d_052202onyx.txt SC 13D 28821
3 STOCK AND WARRANT PURCHASE AGREEMENT exb.txt EX-99 93130
  Complete submission text file 0000904454-02-000092.txt   123915
Mailing Address 3031 RESEARCH DRIVE RICHMOND CA 94806
Business Address 3031 RESEARCH DR BLDG A RICHMOND CA 94806 5102229700
ONYX PHARMACEUTICALS INC (Subject) CIK: 0001012140 (see all company filings)

IRS No.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45955 | Film No.: 02666007
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE PALMER SQ PRINCETON NJ 08542
Business Address ONE PALMER SQ PRINCETON NJ 08542
DOMAIN PARTNERS IV LP (Filed by) CIK: 0001077714 (see all company filings)